Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects

Richard F. Brubaker, Cory J. Ingram, Erik O. Schoff, Cherie B. Nau

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Objective: To compare the efficacy of combinations of betaxolol- brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow and ocular hypotensive agents. Design: Placebo-controlled, masked comparison of the two drug combinations. Participants: Twenty-five normal human volunteers with the fellow eye serving as control. Methods or Testing: Fluorophotometric measurement of aqueous humor flow and pneumatonometric measurement of intraocular pressure. Main Outcome Measures: Aqueous humor flow and intraocular pressure. Results: The betaxolol-brinzolamide combination lowered aqueous flow 39% to 44%, and the timolol-dorzolamide combination lowered aqueous flow 51%. The betaxolol-brinzolamide combination lowered intraocular pressure 14% to 19%, and the timolol-dorzolamide combination lowered it 18% to 24%. Conclusions: Both drug combinations were effective; the timolol- dorzolamide combination appeared to be the more effective of the two after short-term exposure (24 hours). (C) 2000 by the Mayo Foundation.

Original languageEnglish (US)
Pages (from-to)283-287
Number of pages5
JournalOphthalmology
Volume107
Issue number2
DOIs
StatePublished - Feb 1 2000

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Comparison of the efficacy of betaxolol-brinzolamide and timolol- dorzolamide as suppressors of aqueous humor flow in human subjects'. Together they form a unique fingerprint.

  • Cite this